Andrea M. Gross, M.D.

Andrea M. Gross, M.D.

  • Center for Cancer Research
  • National Cancer Institute
Pediatric Oncology Branch


Dr. Gross is a pediatric oncologist who focuses on clinical trials research and tumor predisposition syndromes, such as neurofibromatosis type 1 (NF1).  Her areas of interest include developing and utilizing functional outcome measures for tumor predisposition syndromes, working with rare disease patient advocates to increase patient engagement in clinical trial design and dealing with the challenge of medication adherence in the NF1 population.

Areas of Expertise

Neurofibromatosis Type 1 (NF1)
Pediatric Oncology

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them.

Clinical Trials